I Bio reported raising $15.1 Million in an initial SEC Form D filing, from an offering of $15.1 Million
Round Type
Venture
New YorkManufacturingBiotechnologyQuick answer
iBio raised $15.1 Million in a funding round, dated March 26, 2024. iBio is based in New York, New York, United States.
- How much did iBio raise?
- iBio raised $15.1 Million in a funding round on March 26, 2024.
- What does iBio do?
- iBio is a cutting-edge biotech company leveraging AI and advanced computational biology to develop next-generation biopharmaceuticals for cardiometabolic diseases, obesity, cancer and other hard-to-treat diseases.
- Where is iBio based and how big is it?
- iBio is based in New York, New York, United States. Fundz records about 16 employees.
- Who are the decision-makers at iBio?
- Fundz holds 2 contacts at iBio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at iBio, and when
A new round usually means iBio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day iBio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at iBio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at iBio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment iBio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
iBio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.